AAAAAA
Results:
1-15
|
Results: 15
Authors:
Ferrara, R
Zanovello, A
Bortolato, S
White, INH
Manno, M
Citation: R. Ferrara et al., Bioactivation and cytotoxicity of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) in isolated rat hepatocytes, PHARM TOX, 88(4), 2001, pp. 192-197
Authors:
White, INH
Citation: Inh. White, Anti-oestrogenic drugs and endometrial cancers, TOX LETT, 120(1-3), 2001, pp. 21-29
Authors:
Styles, JA
Davies, R
Fenwick, S
Walker, J
White, INH
Smith, LL
Citation: Ja. Styles et al., Tamoxifen mutagenesis and carcinogenesis in livers of lambda/lacI transgenic rats: selective influence of phenobarbital promotion, CANCER LETT, 162(1), 2001, pp. 117-122
Authors:
White, INH
Carthew, P
Davies, R
Styles, J
Brown, K
Brown, JE
Smith, LL
Martin, EA
Citation: Inh. White et al., Short-term dosing of alpha-hydroxytamoxifen results in DNA damage but doesnot lead to liver tumours in female Wistar/Han rats, CARCINOGENE, 22(4), 2001, pp. 553-557
Authors:
Green, AR
Parrott, EL
Butterworth, M
Jones, PS
Greaves, P
White, INH
Citation: Ar. Green et al., Comparisons of the effects of tamoxifen, toremifene and raloxifene on enzyme induction and gene expression in the ovariectomised rat uterus, J ENDOCR, 170(3), 2001, pp. 555-564
Authors:
Parrott, E
Butterworth, M
Green, A
White, INH
Greaves, P
Citation: E. Parrott et al., Adenomyosis - A result of disordered stromal differentiation, AM J PATH, 159(2), 2001, pp. 623-630
Authors:
Smith, LL
Brown, K
Carthew, P
Lim, CK
Martin, EA
Styles, J
White, INH
Citation: Ll. Smith et al., Chemoprevention of breast cancer by tamoxifen: Risks and opportunities, CR R TOXIC, 30(5), 2000, pp. 571-594
Authors:
Carthew, P
Edwards, RE
Nolan, BM
Martin, EA
Heydon, RT
White, INH
Tucker, MJ
Citation: P. Carthew et al., Tamoxifen induces endometrial and vaginal cancer in rats in the absence ofendometrial hyperplasia, CARCINOGENE, 21(4), 2000, pp. 793-797
Authors:
Boocock, DJ
Maggs, JL
Brown, K
White, INH
Park, BK
Citation: Dj. Boocock et al., Major inter-species differences in the rates of O-sulphonation and O-glucuronylation of alpha-hydroxytamoxifen in vitro: a metabolic disparity protecting human liver from the formation of tamoxifen-DNA adducts, CARCINOGENE, 21(10), 2000, pp. 1851-1858
Authors:
Riley, J
Styles, J
Verschoyle, RD
Stanley, LA
White, INH
Gant, TW
Citation: J. Riley et al., Association of tamoxifen biliary excretion rate with prior tamoxifen exposure and increased mdr1b expression, BIOCH PHARM, 60(2), 2000, pp. 233-239
Authors:
Boocock, DJ
Maggs, JL
Brown, K
White, INH
Park, BK
Citation: Dj. Boocock et al., Glucuronylation of alpha-hydroxytamoxifen: a deactivation pathway in humans?, BR J CL PH, 47(5), 1999, pp. 578-579
Authors:
White, INH
Citation: Inh. White, The tamoxifen dilemma, CARCINOGENE, 20(7), 1999, pp. 1153-1160
Authors:
Brown, K
Heydon, RT
Jukes, R
White, INH
Martin, EA
Citation: K. Brown et al., Further characterization of the DNA adducts formed in rat liver after the administration of tamoxifen, N-desmethyltamoxifen or N,N-didesmethyltamoxifen, CARCINOGENE, 20(10), 1999, pp. 2011-2016
Authors:
Boocock, DJ
Maggs, JL
White, INH
Park, BK
Citation: Dj. Boocock et al., alpha-hydroxytamoxifen, a genotoxic metabolite of tamoxifen in the rat: identification and quantification in vivo and in vitro, CARCINOGENE, 20(1), 1999, pp. 153-160
Activation of transcription by estrogen receptor alpha and beta is cell type- and promoter-dependent
Authors:
Jones, PS
Parrott, E
White, INH
Citation: Ps. Jones et al., Activation of transcription by estrogen receptor alpha and beta is cell type- and promoter-dependent, J BIOL CHEM, 274(45), 1999, pp. 32008-32014
Risultati:
1-15
|